Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review - Wikidata - wikimedia - TriplyDB

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

http://www.wikidata.org/entity/Q27005619

about

Safety and Toxicology of Cannabinoids Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence An Atmospheric Pressure Ionization MS/MS Assay using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and Urine.Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.Cannabidiol as a Potential Treatment for Anxiety Disorders.Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats Molecular Targets of Cannabidiol in Neurological Disorders Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice Associations Between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis vs Tobacco Users Screening Medications for the Treatment of Cannabis Use Disorder.Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse.Alternative Interventions to Prevent Oxidative Damage following Ischemia/Reperfusion Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting Molecular Targets of the Phytocannabinoids: A Complex Picture.The Endocannabinoid System and its Modulation by Phytocannabinoids.Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors.Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of Inhaled Δ9-Tetrahydrocannabinol and Cannabidiol Reveals No Effect on Sweet Taste Intensity Perception and Liking in Humans.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease.Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.Molecular Pharmacology of Phytocannabinoids.Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review.Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.Mechanisms contributing to cognitive deficits in cannabis users.Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology.Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series.Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia?Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System

P2860

Q26798333-C0E2A846-AE3D-4BCE-843A-AFDCF0A18511 Q27324505-07F4CD2A-3834-442A-893C-76A76FF676FA Q28071794-DFBAEF05-A2DB-4517-879F-789D8BFCDDB5 Q28075499-72F9F59E-38A5-4D5B-AED4-E280DB9FD444 Q33470761-DB2E6101-D9F9-4E14-9BA9-6D6AAABA81B3 Q33577070-79AE5CD4-5333-42A8-93F5-BA51CC402452 Q33798050-5EE4D883-DFBC-4959-9954-A1FAE96A86E5 Q34492624-07D1C0B0-3D10-49CC-A2C5-05780366F1C9 Q34522740-6E4952AA-6727-4021-9F9C-5373FC2DDC2D Q34557613-A1001204-892D-4D08-BFAA-8FDEC9DA13AB Q34676610-641A681C-50B0-40EA-85BD-0369728E359D Q35223942-4319105F-A52F-4E69-8E32-855970B2EFF7 Q36157649-70A1530D-8CBB-4B35-86A0-C3038BE659D9 Q36744227-DAC2AED2-E733-42C9-A401-A8A30BBDC33C Q36954728-943C1258-E852-4F5A-AC8D-E7206F2099F2 Q37075261-6BF903D2-ED19-4F65-9EDF-39C0396B7189 Q37187618-FC74BA1D-1820-457B-B9FB-46020F89185D Q37274656-93126DB4-0351-41D8-8685-4679296CDB83 Q37306421-5E5D38E5-D4DD-4BBE-A4AF-E634F9A7AB05 Q37578724-79B630DD-C193-4A58-AB19-3F9A187C874B Q37645616-779BCEEB-9774-468A-A131-A82F5F1B3D14 Q37692746-03CD39AD-9ABD-43DA-814A-3A0160AD348D Q38566339-72203992-FDBC-419B-B59F-602EC3B5CF11 Q38572902-27122A69-8A8A-43F8-B2AD-802229752F47 Q38598493-037A57E4-E238-4911-881C-DC1869715491 Q38684679-F86AAA89-D762-4215-94EC-72587EE1018E Q38809361-D6E938C5-CA4D-4487-AEC3-6D2AA4D8EB29 Q38848638-DD6A26C7-CE2D-4893-97BF-2FC6B034FBC1 Q38957531-C644DD99-1A4B-48DE-AD64-6C40DB5E8668 Q38973739-11CEE296-2CC2-4C53-BE3D-0F3295287493 Q39102188-B3508C5A-0DB8-4EA0-A5B1-96BA808759BA Q39154540-C94720BE-8ED1-4325-95EC-543CB2013012 Q39166556-257073F8-5882-49AF-84AD-0850CD926F79 Q39245794-B514D997-3A0D-466C-91D3-8F989884E39C Q39556033-D4141292-15B7-4EE7-B8F2-4BA40355909D Q39666956-BC4655D4-E412-41CB-A966-A05C9270FA94 Q40719201-44D71E0A-80A0-41F9-AFDE-6DD62050FE65 Q41560648-67D842F6-A431-4F8C-B315-5A808166D3BF Q41761143-852FC725-D95D-459C-9FF1-50EF9E4EB589 Q42663503-F6F0E1A4-5AF6-441F-8D71-64456F91D37C

P2860

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

http://www.wikidata.org/entity/Q27005619

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@ast

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@en

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@nl

type

label

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@ast

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@en

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@nl

prefLabel

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@ast

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@en

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@nl

P1433

Q27005619-11AD5215-1ADD-4DBE-A38A-3828215EBBCF

P1476

Q27005619-736A52A4-70C6-4E8E-A200-9F96BBBCB2F2

P2093

Q27005619-0436DC11-AE3D-4C1D-9245-3C09B3FD4774

Q27005619-38839FF4-520D-44D5-B808-BBAEF53CFB70

P2860

Q27005619-05676482-823F-4495-8A5F-4E915D9D20F7

Q27005619-0573C0B9-BFFC-4E1E-8663-A94C456006FD

Q27005619-06DDBCCA-C25E-4FE4-9861-14D1408387A7

Q27005619-0908D9CB-B25F-4A4D-A2A5-9FE68AA2E94D

Q27005619-10BE6316-B223-41AA-9307-6A87166E121D

Q27005619-11310900-59FF-444F-B7A4-2C452EC8B83B

Q27005619-161EFB1E-5AB9-478E-85E4-39D1EFAD1A88

Q27005619-18453FE1-53C7-4E89-A86F-C1704BE028CC

Q27005619-1927FB0B-CA1F-42F8-9F65-143D8958F98E

Q27005619-1AA279CE-6184-46E7-9F5A-E3496890AD17

P304

Q27005619-1F444ED7-333E-4360-B005-8AD6FAEBBBB7

P31

Q27005619-1942C7C9-AF97-425B-9EA6-A27227CA5C15

Q27005619-8F945A07-8793-4D4A-AAA7-E39378F06018

P3181

Q27005619-93B23D1F-822E-4D67-9AC7-101B04C77C8A

P356

Q27005619-CDA2BB84-038A-450E-AFBC-6A60FEA893C9

P407

Q27005619-A00BC893-D62E-4BC4-98D5-33CCD6C0DDC1

P433

Q27005619-08E80C5B-D901-4C1B-A338-135B534589BC

P478

Q27005619-AD7EC9A5-1BEB-418A-BB04-104521C73885

P50

Q27005619-9446BC8F-A097-41EC-8FE8-A0A63F56994A

Q27005619-EF777454-FA7E-4764-BF01-2E3B41F275E9

P577

Q27005619-E5BB9B18-80EC-460C-AA99-914220BD4803

P698

Q27005619-B1DB731B-8947-49FB-88C8-23FD5960D05F

P921

Q27005619-5CB7EA12-EDF6-43DC-8A09-F47212B1342F

Q27005619-C609C7C3-B2E4-4B64-A55C-48BEBF44B33F

Q27005619-E0E21DA2-C022-4F7D-87DA-788E3C434F80

P932

Q27005619-298A5E54-EBF9-4590-A0F2-69AD689A40C6

P3181

P356

P1433

British Journal of Pharmacology

P1476

Are cannabidiol and Δ(9) -tetr ...... id system? A systematic review

@en

P2093

John M McPartland

http://www.w3.org/2001/XMLSchema#string

Marnie Duncan

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

The inheritance of chemical phenotype in Cannabis sativa L

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis

P304

737-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

1264375

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/BPH.12944

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Di Marzo

Roger G. Pertwee

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25257544

http://www.w3.org/2001/XMLSchema#string

P921

endocannabinoid system

P932

4301686

http://www.w3.org/2001/XMLSchema#string